Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating t... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Plac... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740122) titled 'AI-Based Stool Image Analysis for Colorectal Neoplasia Risk Assessment' on July 28. Brief S... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739667) titled 'Blood Pressure Measurement Using Vitacam' on July 28. Brief Summary: The purpose of this cl... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738471) titled 'Assessment of Clinical Success of Custom-Made Versus Prefabricated Zirconia Crowns in Pulpot... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More